|
1.
|
|
11 p, 1.3 MB |
Prosthesis-patient mismatch following transcatheter aortic valve replacement for degenerated transcatheter aortic valves : the TRANSIT-PPM international project
/
Testa, Luca (IRCCS Policlinico S. Donato) ;
Casenghi, Matteo (IRCCS Policlinico S. Donato) ;
Criscione, Enrico (IRCCS Policlinico S. Donato) ;
Van Mieghem, Nicolas M. (Erasmus University Medical Center) ;
Tchétché, Didier (Clinique Pasteur) ;
Asgar, Anita W. (Montreal Heart Institute) ;
De Backer, Ole (Copenhagen University Hospital) ;
Latib, Azeem (Montefiore Medical Center) ;
Reimers, Bernhard (CCS Humanitas Research Hospital) ;
Stefanini, Giulio (Humanitas University) ;
Trani, Carlo (Policlinico Universitario A. Gemelli) ;
Giannini, Francesco (Maria Cecilia Hospital) ;
Bartorelli, Antonio (University of Milan) ;
Wojakowski, Wojtek (Medical University of Silesia) ;
Dabrowski, Maciej (National Institute of Cardiology) ;
Jagielak, Dariusz (Medical University) ;
Banning, Adrian P. (John Radcliffe Hospital (Oxford, Regne Unit)) ;
Kharbanda, Rajesh (John Radcliffe Hospital (Oxford, Regne Unit)) ;
Moreno, Raul (Hospital La Paz) ;
Schofer, Joachim (MVZ Department Structural Heart Disease at St. Georg) ;
Brinkmann, Christina (MVZ Department Structural Heart Disease at St. Georg) ;
van Royen, Niels (Radboud University Medical Center) ;
Pinto, Duane (Beth Israel Deaconess Medical Center) ;
Serra, Antoni (Institut d'Investigació Biomèdica Sant Pau) ;
Segev, Amit (Chaim Sheba Medical Center (Israel)) ;
Giordano, Arturo (Pineta Grande Hospital) ;
Brambilla, Nedy (IRCCS Policlinico S. Donato) ;
Agnifili, Mauro. (IRCCS Policlinico S. Donato) ;
Rubbio, Antonio Popolo (IRCCS Policlinico S. Donato) ;
Squillace, Mattia (IRCCS Policlinico S. Donato) ;
Oreglia, Jacopo (Niguarda Ca Granda Hospital) ;
Tanja, Rudolph (Heart and Diabetes Center NRW) ;
McCabe, James M. (University of Washington) ;
Abizaid, Alexander (Instituto do Coração (Incor)) ;
Voskuil, Michiel (University Medical Center) ;
Teles, Rui (Centro Hospitalar de Lisboa Ocidental) ;
Zoccai, Giuseppe Biondi (Mediterranea Cardiocentro) ;
Sondergaard, Lars (Montreal Heart Institute) ;
Bedogni, Francesco (IRCCS Policlinico S. Donato) ;
Universitat Autònoma de Barcelona
A severe prosthesis-patient mismatch (PPM) is associated with adverse outcomes following transcatheter aortic valve replacement (TAVR) for de novo aortic stenosis or a failed surgical bioprosthesis. The impact of severe PPM in patients undergoing TAV-in-TAVR is unknown. [...]
2022 -  10.3389/fcvm.2022.931207
Frontiers in Cardiovascular Medicine, Vol. 9 (29 2022) , p. 931207
|
|
|
2.
|
|
6 p, 1.1 MB |
Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab : part 3 of the open-label, multicenter, phase 1b PAVO study
/
Nahi, Hareth (Karolinska Institute. Department of Medicine) ;
Usmani, Saad Z. (Memorial Sloan Kettering Cancer Center) ;
Mateos, M. V (Hospital Universitario de Salamanca) ;
van de Donk, Niels W C J (Department of Hematology. Vrije Universiteit Amsterdam) ;
Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Plesner, Torben (Vejle Hospital and University of Southern Denmark) ;
Bandyopadhyay, Nibedita (Janssen Research & Development. LLC) ;
Hellemans, Peter (Janssen Research & Development) ;
Tromp, Brenda (Janssen Research & Development. LLC) ;
Nnane, Ivo (Janssen Research & Development. LLC) ;
Zemlickis, Donna (Janssen Research & Development. LLC) ;
Chari, Ajai (Icahn School of Medicine at Mount Sinai) ;
Moreau, Philippe (University Hospital Hôtel-Dieu (Nantes, França))
2023 - 10.1080/10428194.2022.2148221
Leukemia and Lymphoma, Vol. 64 Núm. 2 (2023) , p. 468-472
|
|
|
3.
|
|
18 p, 862.2 KB |
Plain language summary of the MonumenTAL-1 study of talquetamab in people with relapsed or refractory multiple myeloma
/
Chari, Ajai (Mount Sinai School of Medicine, USA) ;
Askari, Elham (Hospital Universitario Fundación Jiménez Díaz) ;
Caers, Jo (Centre Hospitalier Universitaire de Liège, Belgium) ;
Costa, Luciano J. (University of Alabama at Birmingham, USA) ;
Hilder, Brandi W. (Janssen Research & Development, Spring House, USA) ;
Krishnan, Amrita (City of Hope Comprehensive Cancer Center, Duarte, USA) ;
Mateos, M. V (Hospital Universitario de Salamanca) ;
Minnema, Monique C. (University Utrecht, Netherlands) ;
Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Pillarisetti, Kodandaram (Janssen Research & Development, Spring House, USA) ;
Van De Donk, Niels W.C.J. (Vrije Universiteit Amsterdam, Netherlands) ;
Rodríguez-Otero, Paula (Clínica Universidad de Navarra)
What is this summary about? This plain language summary describes the results of a phase 1 research study (or clinical trial) called MonumenTAL-1 published in the New England Journal of Medicine in December 2022. [...]
2023 - 10.2217/fon-2023-0332
Future oncology (London, England), Vol. 19 Núm. 27 (september 2023) , p. 1823-1840
|
|
|
4.
|
|
8 p, 1.0 MB |
Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma
/
Moreau, Philippe (University Hospital Hôtel-Dieu) ;
Van De Donk, Niels WCJ (Department of Hematology. Amsterdam University Medical Center) ;
Nahi, Hareth (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Nooka, Ajay K (Winship Cancer Institute. Emory University) ;
Martin, Thomas (University of California San Francisco) ;
Rosinol, Laura (Hospital Clínic i Provincial de Barcelona) ;
Karlin, Lionel (Centre Hospitalier Lyon Sud) ;
Benboubker, Lotfi (Hôpital Bretonneau) ;
Mateos, Maria-Victoria (University Hospital de Salamanca) ;
Popat, Rakesh (University College London Hospitals) ;
Martínez-López, Joaquín (Hospital Universitario 12 de Octubre (Madrid)) ;
Sidana, Surbhi (Stanford University of Medicine) ;
Delforge, Michele (University of Leuven) ;
Pei, Lixia (Janssen Research & Development) ;
Trancucci, Danielle (Janssen Research & Development) ;
Olyslager, Yunsi (Janssen Research & Development) ;
Uhlar, Clarissa (Janssen Research & Development) ;
Stephenson, Tara (Janssen Research & Development) ;
Rampelbergh, Rian Van (Janssen Research & Development) ;
Banerjee, Arnob (Janssen Research & Development) ;
Kobos, Rachel (Janssen Research & Development) ;
Usmani, Saad Z (Levine Cancer Institute-Atrium Health)
What is this summary about? This is a summary of a phase 1-2 clinical trial called MajesTEC-1. This trial tested the cancer drug teclistamab in people with relapsed or refractory multiple myeloma, a cancer that forms in a certain type of white blood cells known as plasma cells. [...]
2023 - 10.2217/fon-2023-0171
Future oncology (London, England), Vol. 19 Núm. 12 (january 2023) , p. 811-818
|
|
|
5.
|
|
9 p, 603.3 KB |
Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma : Results From the Phase II MajesTEC-1 Study
/
Martin, Thomas G. (University of California San Francisco, USA) ;
Moreau, Philippe (University Hospital Hôtel-Dieu, Nantes, France) ;
Usmani, Saad Z. (Levine Cancer Institute/Atrium Health, Charlotte, NC) ;
Garfall, Alfred (University of Pennsylvania, Philadelphia, PA) ;
Mateos, M. V (Hospital Universitario de Salamanca) ;
San-Miguel, Jesús F. (Clínica Universidad de Navarra) ;
Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Nooka, Ajay K. (Emory University, Atlanta, GA) ;
Rosiñol, Laura (Hospital Clínic i Provincial de Barcelona) ;
Chari, Ajay (Mount Sinai School of Medicine, New York, USA) ;
Karlin, Lionel (Centre Hospitalier Lyon Sud, Pierre-Bénite, France) ;
Krishnan, Amrita (City of Hope National Medical Center (Duarte, Estats Units d'Amèrica)) ;
Bahlis, Nizar (University of Calgary, Canada) ;
Popat, Rakesh (University College London) ;
Besemer, Britta (University of Tuebingen, Tuebingen, Germany) ;
Martínez-López, Joaquín (Hospital Universitario 12 de Octubre (Madrid)) ;
Delforge, Michel (Universitaire Ziekenhuizen Leuven, Belgium) ;
Trancucci, Danielle (Janssen Research & Development, Raritan, NJ) ;
Pei, Lixia (Janssen Research & Development, Raritan, NJ) ;
Kobos, Rachel (Janssen Research & Development, Raritan, NJ) ;
Fastenau, John (Janssen Research & Development, Raritan, NJ) ;
Gries, Katharine S. (Janssen Research & Development, Raritan, NJ) ;
van de Donk, Niels W.C.J. (Amsterdam University Medical Center, Vrije Universiteit Amsterdam, The Netherlands)
Introduction: Patients with relapsed or refractory multiple myeloma (RRMM) report significantly lower HRQoL compared with patients with newly diagnosed MM and experience further deterioration in HRQoL with each relapse and subsequent treatment. [...]
2023 - 10.1016/j.clml.2023.11.001
Clinical Lymphoma, Myeloma & Leukemia, 2023
|
|
|
6.
|
|
9 p, 1012.4 KB |
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity : A cross-sectional analysis from the AB255 Study
/
Pérez-Grijalba, Virginia (Araclon Biotech S.L.) ;
Arbizu, Javier (Clínica Universidad de Navarra) ;
Romero, Judith (Araclon Biotech S.L.) ;
Prieto, Elena (Clínica Universidad de Navarra) ;
Pesini, Pedro (Araclon Biotech S.L.) ;
Sarasa, Leticia (Araclon Biotech S.L.) ;
Guillen, Fernando (Clínica Universidad de Navarra) ;
Monleón, Inmaculada (Araclon Biotech S.L.) ;
San-José, Itziar (Araclon Biotech S.L.) ;
Martínez-Lage, Pablo (Fundación CITA-Alzheimer) ;
Munuera, Josep (Institut de Recerca Sant Joan de Déu) ;
Hernández, Isabel (Instituto de Salud Carlos III) ;
Buendía, Mar (Universitat Internacional de Catalunya) ;
Sotolongo-Grau, Oscar (Universitat Internacional de Catalunya) ;
Alegret, Montserrat (Instituto de Salud Carlos III) ;
Ruiz, Agustín (Instituto de Salud Carlos III) ;
Tárraga, Lluís (Instituto de Salud Carlos III) ;
Boada, Mercè (Instituto de Salud Carlos III) ;
Sarasa, Manuel (Araclon Biotech S.L.) ;
Goñi Imízcoz, Miguel (Hospital Divino Vallés (Burgos)) ;
Pujadas, Francesc ;
Villarejo, Alberto ;
Frank, Ana ;
Peña-Casanova, Jordi ;
Fernández, Manuel ;
Piñol, Gerard ;
Blesa, Rafael (Institut d'Investigació Biomèdica Sant Pau) ;
Gil, Pedro ;
Pascual, Luis F. ;
Aguilar Barberà, Miquel ;
Frisoni, Giovanni B. ;
Matias-Guiu, Jorge ;
Andreasen, Niels ;
Antúnez, Carmen ;
Universitat Autònoma de Barcelona
To facilitate population screening and clinical trials of disease-modifying therapies for Alzheimer's disease, supportive biomarker information is necessary. This study was aimed to investigate the association of plasma amyloid-beta (Aβ) levels with the presence of pathological accumulation of Aβ in the brain measured by amyloid-PET. [...]
2019 - 10.1186/s13195-019-0549-1
Alzheimer's research & therapy, Vol. 11 Núm. 1 (january 2019) , p. 96
|
|
|
7.
|
|
11 p, 405.0 KB |
Implications of estimating road traffic serious injuries from hospital data
/
Pérez, Katherine (Agència de Salut Pública de Barcelona) ;
Weijermars, Wendy (Institute for Road Safety Research (SWOV)) ;
Bos, Niels M. (Institute for Road Safety Research (SWOV)) ;
Filtness, Ashleigh J. (Transport Safety Research Centre. Loughborough University (LOUGH)) ;
Bauer, Robert (Austrian Road Safety Board (KFV)) ;
Johannsen, Heiko (Medical University of Hannover (MHH)) ;
Nuyttens, Nina (Vias institute) ;
Pascal, L. (French Institute of Science and Technology for Transport) ;
Thomas, P. (Loughborough University (LOUGH)) ;
Olabarria Saenz de Viguera, Marta (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
To determine accurately the number of serious injuries at EU level and to compare serious injury rates between different countries it is essential to use a common definition. In January 2013, the High Level Group on Road Safety established the definition of serious injuries as patients with an injury level of MAIS3+(Maximum Abbreviated Injury Scale). [...]
2019 - 10.1016/j.aap.2018.04.005
Accident analysis and prevention, Vol. 130 (september 2019) , p. 125-135
|
|
|
8.
|
|
12 p, 1.1 MB |
Inflammatory biomarkers in Alzheimer's disease plasma
/
Morgan, Angharad R. (Systems Immunity Research Institute and UK Dementia Research Institute Cardiff, Cardiff University (Regne Unit)) ;
Touchard, Samuel (Systems Immunity Research Institute and UK Dementia Research Institute Cardiff, School of Medicine, Cardiff University (Regne Unit)) ;
Leckey, Claire A. (Cardiff University (Regne Unit)) ;
O'Hagan, Caroline (Cardiff University (Regne Unit)) ;
Nevado-Holgado, Alejo (University of Oxford (Regne Unit)) ;
Barkhof, Frederik (University College London) ;
Bertram, Lars (Max Planck Institute for Molecular Genetics (Alemanya)) ;
Blin, Olivier (Aix-Marseille University (França)) ;
Bos, Isabelle (Maastricht University (Països Baixos)) ;
Dobricic, Valerija (University of Lübeck (Alemanya)) ;
Engelborghs, Sebastiaan (Institute Born-Bunge (Bèlgica)) ;
Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (Brescia, Itàlia)) ;
Froelich, Lutz (University of Heidelberg (Alemanya)) ;
Gabel, Silvy (Laboratory for Cognitive Neurology (Leuven, Bèlgica)) ;
Johannsen, Peter (Karolinska Institutet (Stockholm, Sweden)) ;
Kettunen, Petronella (University of Gothenburg (Gothenburg, Suècia)) ;
Kłoszewska, Iwona (Medical University of Lodz (Lodz, Poland)) ;
Legido-Quigley, Cristina (Imperial College London) ;
Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ;
Martinez-Lage, Pablo (Fundación CITA-Alzheimer Fundazioa (San Sebastian, Spain)) ;
Mecocci, Patrizia (University of Perugia (Itàlia)) ;
Meersmans, Karen (Laboratory for Cognitive Neurology (Bèlgica)) ;
Molinuevo, José Luis (Universitat Pompeu Fabra) ;
Peyratout, Gwendoline (Lausanne University Hospital (Suïssa)) ;
Popp, Julius (Hopitaux Universitaires Geneve and Universite de Geneve (Suïssa)) ;
Richardson, Jill (GlaxoSmithKline R&D (Regne Unit)) ;
Sala, Isabel (Institut d'Investigació Biomèdica Sant Pau) ;
Scheltens, Philip (Vrije Universiteit (Països Baixos)) ;
Streffer, Johannes (University of Antwerp) ;
Soininen, Hikka (University of Eastern Finland) ;
Tainta, Mikel (Fundación CITA Alzheimer (Sant Sebastià, País Basc)) ;
Teunissen, Charlotte E (University Hospitals Leuven (Bèlgica)) ;
Tsolaki, Magda (AHEPA University Hospital (Grècia)) ;
Vandenberghe, Rik (Amsterdam University Medical Centers (Països Baixos)) ;
Visser, Pieter Jelle (Maastricht University (Països Baixos)) ;
Vos, Stephanie (Maastricht University (Països Baixos)) ;
Wahlund, Lars Olof (Karolinska Institutet (Estocolm, Suècia)) ;
Wallin, Anders (University of Gothenburg Sahlgrenska Academy) ;
Westwood, Sarah (University of Oxford (Regne Unit)) ;
Zetterberg, Henrik (UK Dementia Research Institute (Londres, Regne Unit)) ;
Lovestone, Simon (University of Oxford (Regne Unit)) ;
Morgan, B. Paul (Cardiff University (Regne Unit)) ;
Bullmore, Edward (University of Cambridge (Regne Unit)) ;
Bhatti, Junaid (University of Cambridge (Regne Unit)) ;
Chamberlain, Samuel J. (University of Cambridge (Regne Unit)) ;
Correia, Marta Morgado (University of Cambridge (Regne Unit)) ;
Crofts, Anna L. (Université de Sherbrooke (Canadà)) ;
Dickinson, Amber (Addenbroke's Hospital (Cambridge, Regne Unit)) ;
Foster, Andy C. (Cambridgeshire and Peterborough NHS Foundation Trust (Regne Unit)) ;
Kitzbichler, Manfred G. (University of Cambridge (Regne Unit)) ;
Knight, Clare (Cambridgeshire and Peterborough NHS Foundation Trust (Regne Unit)) ;
Lynall, Mary-Ellen (University of Cambridge (Regne Unit)) ;
Maurice, Christina (University of Cambridge (Regne Unit)) ;
O'Donnell, Ciara M. (University College London (Regne Unit)) ;
Pointon, Linda J. (University of Cambridge (Regne Unit)) ;
St George Hyslop, Peter (University of Cambridge (Regne Unit)) ;
Turner, Lorinda (University of Cambridge (Regne Unit)) ;
Vertes, Petra E. (University of Cambridge (Regne Unit)) ;
Widmer, Barry (University of Cambridge (Regne Unit)) ;
Williams, Guy (University of Cambridge (Regne Unit)) ;
Cavanagh, Jonathan T. O. (Karolinska Institutet (Estocolm, Suècia)) ;
Deith, Catherine (Southern General Hospital Glasgow (Escòcia)) ;
Farmer, Scott (Bio Med Sciences Inc.(Galveston, Estats Units)) ;
McClean, John (NHS Greater Glasgow and Clyde (Glasgow, Escòcia)) ;
McColl, Alison (College of Medical, Veterinary & Life Sciences (Glasgow, Escòcia)) ;
McPherson, Andrew (Addenbrooke's Hospital (Cambridge, Regne Unit)) ;
Scouller, Paul (Addenbrooke's Hospital (Cambridge, Regne Unit)) ;
Sutherland, Murray (NHS Greater Glasgow and Clyde (Glasgow, Escòcia)) ;
Boddeke, Erik W.G.M. (Københavns UniversitetThe institution (Copenhaguen, Dinamarca)) ;
Khan, Shahid (GlaxoSmithKline plc. (Regne Unit)) ;
Murphy, Philip Stephen (GlaxoSmithKline plc. (Regne Unit)) ;
Parker, Christine A. (Wellcome Trust (Londres, Regne Unit)) ;
Patel, Jai (GlaxoSmithKline plc. (Regne Unit)) ;
Jones, Declan (Janssen Pharmaceuticals (Titusville, Estats Units)) ;
de Boer, Peter (Janssen Research & Development (Beerse, Bèlgica)) ;
Kemp, John A. (KU Leuven- University Hospital Leuven (Bèlgica)) ;
Drevets, Wayne Curtis (Janssen Research & Development (Beerse, Bèlgica)) ;
Nye, Jeffrey S. (Janssen Research & Development (Beerse, Bèlgica)) ;
Wittenberg, Gayle M. (Janssen Research & Development (Beerse, Bèlgica)) ;
Isaac, John T.R. (Johnson & Johnson (Estats Units)) ;
Bhattacharya, Anindya (Janssen Research & Development (Beerse, Bèlgica)) ;
Carruthers, Niicholas L. (Janssen Research & Development (Beerse, Bèlgica)) ;
Kolb, Hartmuth Christian (Janssen Research & Development (Beerse, Bèlgica)) ;
Pariante, Carmine M. (King's College London (Regne Unit)) ;
Turkheimer, Federico (King's College London (Regne Unit)) ;
Barker, Gareth John (King's College London (Regne Unit)) ;
Byrom, Heidi (King's College London (Regne Unit)) ;
Cash, Diana (King's College London (Regne Unit)) ;
Cattaneo, Annamaria (King's College London (Regne Unit)) ;
Gee, Anthony (King's College London (Regne Unit)) ;
Hastings, Caitlín N.M. (King's College London (Regne Unit)) ;
Mariani, Nicole (King's College London (Regne Unit)) ;
McLaughlin, Anna Patricia (King's College London (Regne Unit)) ;
Mondelli, Valeria (King's College London (Regne Unit)) ;
Nettis, Maria Antonietta (King's College London (Regne Unit)) ;
Nikkheslat, Naghmeh (King's College London (Regne Unit)) ;
Randall, Karen (King's College London (Regne Unit)) ;
Sheridan, Hannah C. (King's College London (Regne Unit)) ;
Simmons, Camilla (King's College London (Regne Unit)) ;
Singh, Nisha (King's College London (Regne Unit)) ;
Van Loo, Victoria (King's College London (Regne Unit)) ;
Vicente-Rodríguez, Marta (King's College London (Regne Unit)) ;
Wood, Tobias (King's College London (Regne Unit)) ;
Worrell, Courtney (King's College London (Regne Unit)) ;
Zajkowska, Zuzanna (King's College London (Regne Unit)) ;
Plath, Niels (H. Lundbeck A/S (Copenhagen, Dinamarca)) ;
Egebjerg, Jan (H. Lundbeck A/S (Copenhagen, Dinamarca)) ;
Eriksson, Hans (H. Lundbeck A/S (Copenhagen, Dinamarca)) ;
Gastambide, Francois (H. Lundbeck A/S (Copenhagen, Dinamarca)) ;
Adams, Karen Husted (H. Lundbeck A/S (Copenhagen, Dinamarca)) ;
Jeggo, Ross D. (H. Lundbeck A/S (Copenhagen, Dinamarca)) ;
Thomsen, Christian (Aalborg Universitetshospital (Aalborg, Dinamarca)) ;
Pederson, Jan Torleif (H. Lundbeck A/S (Copenhagen, Dinamarca)) ;
Campbell, Brian M. (Lundbeck Research USA Inc. (Deerfield, Estats Units)) ;
Möller, Thomas (Lundbeck Research USA Inc. (Deerfield, Estats Units)) ;
Nelson, Bob (H. Lundbeck A/S (Copenhagen, Dinamarca)) ;
Zorn, Stevin H. (Lundbeck Research USA Inc. (Deerfield, Estats Units)) ;
O'Connor, Jason (University of Texas Hlth Sci Ctr San Antonio(Estats Units)) ;
Attenburrow, Mary Jane (Warneford Hospital. NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ;
Baird, Alison (Warneford Hospital. NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ;
Benjamin, Jithen (Warneford Hospital. NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ;
Clare, Stuart (John Radcliffe Hosp, Oxford Ctr Funct MRI Brain (Oxford, Anglaterra)) ;
Cowen, Philip (University of Oxford (Anglaterra)) ;
Huang, I-Shuo Wade (Kennedy Inst Rheumatol (Oxford, Anglaterra)) ;
Hurley, Samuel A. (University of Wisconsin-Madison (Madison, Estats Units)) ;
Jones, Helen (Warneford Hosp, NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ;
Mada, Francisca (Neurosciences & Neurology) ;
Nevado-Holgado, Alejo (University of Oxford (Anglaterra)) ;
Oladejo, Akitayo (Metropolitan Hospital Center (New York, Estats Units)) ;
Ribe, Elena (King's College London (Londres, Anglaterra)) ;
Smith, Katy (Warneford Hospital. NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ;
Vyas, Anviti (University of Oxford (Oxford, Anglaterra)) ;
Hughes, Zoe (Praxis Precision Medicines (Cambridge, Regne Unit)) ;
Balice-Gordon, Rita (Sanofi S.A. (Gentilly, França)) ;
Duerr, James M. (Pfizer Inc.(New York, Estats Units)) ;
Piro, Justin R. (Pfizer Inc.(New York, Estats Units)) ;
Sporn, Jonathan (Gilgamesh Pharmaceut (New York, Estats Units)) ;
Perry, V. Hugh (University of Southampton. Ctr Biol Sci (Hants, Anglaterra)) ;
Cleal, Madeleine (University of Portsmouth (Anglaterra)) ;
Fryatt, Gemma (University of Southampton. Ctr Biol Sci (Hants, Anglaterra)) ;
Gomez-Nicola, Diego (University of Southampton. Ctr Biol Sci (Hants, Anglaterra)) ;
Mancuso, Renzo (University of Southampton (Anglaterra)) ;
Reynolds, Richard (University of Southampton. Ctr Biol Sci (Hants, Anglaterra)) ;
Harrison, Neil (University fo Sussex (Brighton, Anglaterra)) ;
Cercignani, Mara (University fo Sussex (Brighton, Anglaterra)) ;
Clarke, Charlotte L. (University of Sussex (Brighton, Regne Unit)) ;
Hoskins, Elizabeth (Sussex Partnership NHS Foundation Trust (Worthing, Regne Unit)) ;
Kohn, Charmaine (Sussex Partnership NHS Foundation Trust (Worthing, Regne Unit)) ;
Murray, Rosemary (Addenbrooke's Hospital (Cambridge, Regne Unit)) ;
Wilcock, Lauren (Sussex Partnership NHS Fdn Trust (Hove, Anglaterra)) ;
Wlazly, Dominika (Brighton and Sussex University Hospitals NHS Trust (Sussex, Anglaterra)) ;
Mount, Howard T.J. (University of Toronto (Toronto, Canadà)) ;
Universitat Autònoma de Barcelona
Plasma biomarkers for Alzheimer's disease (AD) diagnosis/stratification are a "Holy Grail" of AD research and intensively sought; however, there are no well-established plasma markers. A hypothesis-led plasma biomarker search was conducted in the context of international multicenter studies. [...]
2019 - 10.1016/j.jalz.2019.03.007
Alzheimer's & Dementia, Vol. 15 Núm. 6 (june 2019) , p. 776-787
|
|
|
9.
|
|
14 p, 1.5 MB |
Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis
/
Fernández, Javier (Hospital Clínic i Provincial de Barcelona) ;
Clària, J (Hospital Clínic i Provincial de Barcelona) ;
Amorós, Alex (Grifols) ;
Aguilar, Ferran (Grifols) ;
Castro, Miriam (Hospital Clínic i Provincial de Barcelona) ;
Casulleras, Mireia (Hospital Clínic i Provincial de Barcelona) ;
Acevedo, Juan (Derriford Hospital) ;
Duran, Marta (Hospital Clínic i Provincial de Barcelona) ;
Nuñez, Laura (Grifols) ;
Costa, Montserrat (Grifols) ;
Torres, Mireia (Grifols) ;
Horrillo, Raquel (Grifols) ;
Ruiz-del-Árbol, Luis (Hospital Universitario Ramón y Cajal (Madrid)) ;
Villanueva, Càndid (Institut d'Investigació Biomèdica Sant Pau) ;
Prado, Veronica (Hospital Clínic i Provincial de Barcelona) ;
Arteaga, Mireya (Hospital Clínic i Provincial de Barcelona) ;
Trebicka, Jonel (University Hospital of Bonn) ;
Angeli, Paolo (University of Padova) ;
Merli, Manuela (Sapienza University of Rome) ;
Alessandria, Carlo (San Giovanni Battista Hospital) ;
Aagaard, Niels Kristian (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Soriano, German (Institut d'Investigació Biomèdica Sant Pau) ;
Durand, Francois (Hopital Beaujon) ;
Gerbes, Alexander L. (LMU Munich) ;
Gustot, Thierry (Erasme Hospital (ULB)) ;
Welzel, Tania M. (Goethe University) ;
Salerno, Francesco (Policlinico IRCCS San Donato) ;
Bañares, Rafael (Hospital General Universitario Gregorio Marañón) ;
Vargas Blasco, Víctor (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Albillos, Agustín (Hospital Universitario Ramón y Cajal (Madrid)) ;
Silva, Anibal (Hospital Clínic i Provincial de Barcelona) ;
Morales Ruiz, Manuel (Hospital Clínic i Provincial de Barcelona) ;
García-Pagán, JC. (Hospital Clínic i Provincial de Barcelona) ;
Pavesi, Marco (Grifols) ;
Jalan, Rajiv (Royal Free Hospital) ;
Bernardi, Mauro (University of Bologna) ;
Moreau, Richard (Université Paris Diderot-Paris 7) ;
Páez, Antonio (Grifols) ;
Arroyo, Vicente (Grifols) ;
Universitat Autònoma de Barcelona
We investigated the effect of albumin treatment (20% solution) on hypoalbuminemia, cardiocirculatory dysfunction, portal hypertension, and systemic inflammation in patients with decompensated cirrhosis with and without bacterial infections. [...]
2019 - 10.1053/j.gastro.2019.03.021
Gastroenterology, Vol. 157 Núm. 1 (july 2019) , p. 149-162
|
|
|
10.
|
|
6 p, 1.5 MB |
The global pandemic and changes in women's reproductive health : an observational study
/
Haile, Liya (Independent Contractor) ;
van de Roemer, Niels (Valley Electronics AG) ;
Gemzell-Danielsson, Kristina (Department of Women's and Children's Health. Karolinska Institutet) ;
Perelló Capó, Josep (Institut d'Investigació Biomèdica Sant Pau) ;
Lete Lasa, Luis Ignacio (Hospital Universitario Araba. Servicio de Obstetricia y Ginecología) ;
Vannuccini, Silvia (Department of Experimental. Clinical and Biomedical Sciences. Careggi University Hospital. Florence) ;
Koch, Martin C. (Department of Obstetrics and Gynecology. Anregiomed Ansbach Klinikum) ;
Hildebrandt, Thomas (Frauenklinik. Universitätsklinikum Erlangen) ;
Calaf Alsina, Joaquim (Institut d'Investigació Biomèdica Sant Pau)
Objective: The COVID-19 global pandemic has led to the death of millions around the world and impacted the overall health of many people. In this article we aim to compare reproductive health indicators in the first 6 months of 2020 to the prior year, as well as explore stress and quality of life during this time. [...]
2022 - 10.1080/13625187.2021.2024161
European Journal of Contraception and Reproductive Health Care, Vol. 27 Núm. 2 (2022) , p. 102-106
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
